CNS Neurotransmitters and Neuromodulators
eBook - ePub

CNS Neurotransmitters and Neuromodulators

Acetylcholine

Trevor W. Stone

  1. 272 pages
  2. English
  3. ePUB (adapté aux mobiles)
  4. Disponible sur iOS et Android
eBook - ePub

CNS Neurotransmitters and Neuromodulators

Acetylcholine

Trevor W. Stone

DĂ©tails du livre
Aperçu du livre
Table des matiĂšres
Citations

À propos de ce livre

The series CNS Neurotransmitters and Neuromodulators is destined to be the definitive reference work on the physiology and pharmacology of the central nervous system. Written by an outstanding group of international authors, chapters cover a wide range of interdisciplinary aspects of the subject.
This first volume includes an in-depth examination of acetylcholine, ranging from the localization of synthetic enzymes through electrophysiology, pharmacology, and molecular biology to behavioral importance in learning and memory. This indispensable and comprehensive reference keeps you abreast of new developments in several areas of neuroscience.

Foire aux questions

Comment puis-je résilier mon abonnement ?
Il vous suffit de vous rendre dans la section compte dans paramĂštres et de cliquer sur « RĂ©silier l’abonnement ». C’est aussi simple que cela ! Une fois que vous aurez rĂ©siliĂ© votre abonnement, il restera actif pour le reste de la pĂ©riode pour laquelle vous avez payĂ©. DĂ©couvrez-en plus ici.
Puis-je / comment puis-je télécharger des livres ?
Pour le moment, tous nos livres en format ePub adaptĂ©s aux mobiles peuvent ĂȘtre tĂ©lĂ©chargĂ©s via l’application. La plupart de nos PDF sont Ă©galement disponibles en tĂ©lĂ©chargement et les autres seront tĂ©lĂ©chargeables trĂšs prochainement. DĂ©couvrez-en plus ici.
Quelle est la différence entre les formules tarifaires ?
Les deux abonnements vous donnent un accĂšs complet Ă  la bibliothĂšque et Ă  toutes les fonctionnalitĂ©s de Perlego. Les seules diffĂ©rences sont les tarifs ainsi que la pĂ©riode d’abonnement : avec l’abonnement annuel, vous Ă©conomiserez environ 30 % par rapport Ă  12 mois d’abonnement mensuel.
Qu’est-ce que Perlego ?
Nous sommes un service d’abonnement Ă  des ouvrages universitaires en ligne, oĂč vous pouvez accĂ©der Ă  toute une bibliothĂšque pour un prix infĂ©rieur Ă  celui d’un seul livre par mois. Avec plus d’un million de livres sur plus de 1 000 sujets, nous avons ce qu’il vous faut ! DĂ©couvrez-en plus ici.
Prenez-vous en charge la synthÚse vocale ?
Recherchez le symbole Écouter sur votre prochain livre pour voir si vous pouvez l’écouter. L’outil Écouter lit le texte Ă  haute voix pour vous, en surlignant le passage qui est en cours de lecture. Vous pouvez le mettre sur pause, l’accĂ©lĂ©rer ou le ralentir. DĂ©couvrez-en plus ici.
Est-ce que CNS Neurotransmitters and Neuromodulators est un PDF/ePUB en ligne ?
Oui, vous pouvez accĂ©der Ă  CNS Neurotransmitters and Neuromodulators par Trevor W. Stone en format PDF et/ou ePUB ainsi qu’à d’autres livres populaires dans Sciences biologiques et Biologie. Nous disposons de plus d’un million d’ouvrages Ă  dĂ©couvrir dans notre catalogue.

Informations

Éditeur
CRC Press
Année
2020
ISBN
9781000142112
Édition
1
Sous-sujet
Biologie

Chapter 1

The Localization of Cholinergic Neurons and Markers in the CNS

Ricardo Martínez-Murillo and José Rodrigo

CONTENTS
I.
Introduction
II.
Considerations on the Methodologies for Visualizing Cholinergic Structures
A. AChE Histochemistry
B. AChE Pharmacohistochemistry
C. Immunocytochemistry of ACh
D. Immunocytochemistry of ChAT
E. In Situ Hybridization of ChAT mRNA
F. Cytochemical Markers of Cholinergic Neurons Other Than ChAT
III.
Organization and Major Projections of Cholinergic Neurons of the Brain
A. Cholinergic Neurons in the Telencephalon
1. Projection Neurons
2. Local Circuit Neurons
B. Cholinergic Neurons in the Diencephalon
C. Cholinergic Neurons in the Mesencephalon, Pons, and Medulla
1. Midbrain and Pons
2. Spinal Cord
D. Cholinergic Neurons in the Cerebellum
IV.
Cytological Characteristics of Central Cholinergic Neurons
A. Light Microscopy
B. Electron Microscopy
C. Cholinergic Terminals
V.
Transmitter-Specific Afferents to Central Cholinergic Neurons
Acknowledgments
References
Summary: Convincing evidence that acetylcholine (ACh) is a neurotransmitter contained in a variety of central nervous system pathways has been available for some years (see Kasa1 and Wainer et al., 2 for a broad overview), ACh occupying a historically senior position among neurotransmitter candidates. ACh was first described by Loewi (1921) as “Vagustoff’ in the frog heart. However, only in the last few years has the field of neuroanatomy allowed, after a growth in research technology, the unequivocal visualization of cholinergic structures. Convincing conclusions on the cholinergic neuroanatomy of the central nervous system were gained by using histochemical tools, including AChE pharmacohistochemistry, immunocytochemistry, and in situ hybridization procedures. In addition, the anatomic technology has benefited from an interdisciplinary strategy, and it is now possible to combine behavioral or physiological experiments with tracing and/or lesioning of neuronal pathways and with histochemical characterization of the pathways involved. These methodologies will be discussed briefly below.

I. INTRODUCTION

The cholinergic system in the central nervous system (CNS) consists of several neuronal components which are localized throughout the rostrocaudal extent of the brain and spinal cord. Since there was not any available histochemical procedure for direct visualization of ACh, the demonstration of the ACh inactivating enzyme — acetyl cholinesterase (AChE) — was first employed, in combination with lesion- induced procedures, for an earliest anatomic clarification of the CNS cholinergic system in a classical series of experiments.3, 4, 5 These studies are of exceptional relevance in the history of chemical neuroanatomy in that they were among the first to be developed for the general purpose of identifying chemically distinctive classes of cells. These experiments3, 4, 5 were based on the hypothesis that cholinergic neurons contain detectable levels of AChE in the cell body and processes. Shute and Lewis’s consequential conclusion was the identification of two major cholinergic afferents to the forebrain, termed dorsal and ventral tegmental pathways, arising in the pontomesencephalic region. The ventral tegmental AChE pathway described by Shute and Lewis represents the dopamine-containing projection system that originates in the substantia nigra and ventral tegmental area project to the striatum, nucleus accumbens, olfactory tubercle, and frontal cortex.6, 7, 8 It is well known that the AChE ventral tegmental pathway consistently lacks the ACh synthesizing enzyme, choline acetyltransferase (ChAT), considered as an unquestionable marker for cholinergic structures.9 Therefore, although the histochemical description concerning the ventral tegmental AChE-containing pathway to the forebrain is precise, the conclusion concerning the cholinergic nature of this projection was erroneous. Nevertheless, the cholinergic nature of some other pathways described as containing heavy AChE staining by Shute and Lewis4 and Lewis and Shute,5 has been subsequently confirmed, for example, the septo-hippocampal pathway10 and the dorsal tegmental projection to the forebrain.11
In general, the use of AChE histochemistry for examining cholinergic neurons has resulted in conflicting results. In the cerebral cortex, for example, some investigators have not found stained cell bodies following AChE histochemistry, concluding that the cortical mantle does not contain intrinsic cholinergic perikarya.12, 13, 14, 15 Others, however, have reported strong staining in a population of AChE- positive cortical cells.16,17 However, these cells were found to be non-cholinergic.18
Extensive basic and clinical literature has linked ACh with memory function. These studies give information on how the central cholinergic system is involved in functions representing the highest levels of integration, including cortical arousal, sleep-wakefulness cycles, selective attention, learning, memory, and discrimination processes (see Arendt et al.,19 Dekker et al.,20 and Jones,21 for a broad overview), as well as in cortical sensory processing.22 These facts inspired an effort to better define the role that the central cholinergic system plays in human cognitive processes. To date, however, the precise neuronal circuits involved and the physiological basis of the control of memory are still relatively poorly understood. Impairment of central cholinergic function has been associated with normal aging processes and in a number of neurological diseases associated with amnesia or dementia including Alzheimer’s, Parkinson’s and Korsakoff s diseases; dementia of the Alzheimer’s type; postalcoholic dementia; and others.19,23, 24, 25 Cholinergic neurons have also been implicated in delirium in demented patients26 and schizophrenia.27 A decay in neurochemical markers linked to cholinergic function (ChAT, AChE, and muscarinic binding sites) in the cerebral cortex was found to be correlated with the grade of impairment of cognitive function and with the extent of damage to the cholinergic cortical projection system in the basal forebrain.25,28, 29, 30 It is, however, unclear as to whether these cholinergic changes are the cause or result of the disease.31, 32, 33 Because of central cholinergic vulnerability in neurological disorders underlying cognitive deterioration, major research to establish the role of cholinergic neurons in these processes was attempted with the aim of providing potential therapeutic trials in patients exhibiting cognitive deficits.
Approximately 70% of the cholinergic innervation of the neocortex, hippocampus, amygdala, and olfactory bulb arises from neurons in the basal forebrain,34 through which cholinergic transmission may modulate the activity of these telencephalic areas. It has been reported that 30% of neocortical neurons is cholinoceptive, and for most of these application of ACh increases the rate of firing.35 In addition, it seems that ACh released from cholinergic fibers of the basalocortical pathway influences the morphological development of the cerebral cortex36 and exerts a facilitatory, permissive role, in processes of synaptic plasticity during a critical postnatal period37,38 and during adulthood.39 While there is ample evidence for a role of ACh in the control of cerebral blood flow, it appears that the cortical cholinergic afferents originating in the basal forebrain are not involved in such an event.40,41 It is presumed that ACh released from intrinsic cortical cholinergic cells may mediate the cerebrovascular action.
The proven implication of central cholinergic transmission in higher brain processes, as well as in neocortical development and plasticity, has made understanding of the morphology and distribution of cholinergic neurons the subject of considerable attention and continued reinvestigation and reappraisal. To elucidate the structural organization, cytochemistry, and functional connections of the central cholinergic system in different species will provide a new viewpoint relevant to its functional significance in normal and diseased brains, particularly the pathophysiological implications of its degeneration in Alzheimer’s disease and the dementia acco...

Table des matiĂšres

  1. Cover
  2. Title Page
  3. Copyright Page
  4. Preface
  5. The Editor
  6. Contributors
  7. Table of Contents
  8. Chapter 1 The Localization of Cholinergic Neurons and Markers in the CNS
  9. Chapter 2 Subtypes of Neuronal Muscarinic Receptors: Pharmacological Criteria
  10. Chapter 3 Subtypes of Muscarinic Receptors: Receptor Structure and Molecular Biology
  11. Chapter 4 Distribution of Muscarinic Acetylcholine Receptors in the CNS
  12. Chapter 5 Distribution of Nicotinic Receptors in the CNS
  13. Chapter 6 Function of Nicotinic Receptors in the CNS
  14. Chapter 7 Electrophysiological Effects of Acetylcholine on Central Neurons (Whole Cells and Interactions)
  15. Chapter 8 Acetylcholine-Operated Ionic Conductances in Central Neurons
  16. Chapter 9 Neurochemical Transduction Processes Associated with Neuronal Muscarinic Receptors
  17. Chapter 10 Compartmentalization and Release from Neurons in the CNS
  18. Chapter 11 Muscarinic Acetylcholine Receptors and Long-Term Potentiation of Synaptic Transmission
  19. Chapter 12 Nicotinic Receptors and Information Processing
  20. Chapter 13 Cholinergic Neurons and Memory: An Historical Perspective and Overview of Current Research
  21. Chapter 14 Nerve Growth Factor: Influence on Cholinergic Neurons in the CNS
  22. Index
Normes de citation pour CNS Neurotransmitters and Neuromodulators

APA 6 Citation

Stone, T. (2020). CNS Neurotransmitters and Neuromodulators (1st ed.). CRC Press. Retrieved from https://www.perlego.com/book/2013924/cns-neurotransmitters-and-neuromodulators-acetylcholine-pdf (Original work published 2020)

Chicago Citation

Stone, Trevor. (2020) 2020. CNS Neurotransmitters and Neuromodulators. 1st ed. CRC Press. https://www.perlego.com/book/2013924/cns-neurotransmitters-and-neuromodulators-acetylcholine-pdf.

Harvard Citation

Stone, T. (2020) CNS Neurotransmitters and Neuromodulators. 1st edn. CRC Press. Available at: https://www.perlego.com/book/2013924/cns-neurotransmitters-and-neuromodulators-acetylcholine-pdf (Accessed: 15 October 2022).

MLA 7 Citation

Stone, Trevor. CNS Neurotransmitters and Neuromodulators. 1st ed. CRC Press, 2020. Web. 15 Oct. 2022.